Is Insomnia a Risk Factor for Decreased Influenza Vaccine Response?

Area of Science:

• Immunology
• Sleep Medicine
• Public Health

Background:

• Sleep disturbances, particularly insomnia, are prevalent in young adults.
• Immune response to vaccination can vary significantly between individuals.
• Understanding factors influencing vaccine efficacy is crucial for public health strategies.

Purpose of the Study:

• To investigate the impact of insomnia on influenza vaccine immunogenicity in healthy young adults.
• To compare serum antibody levels pre- and post-influenza vaccination in college students with and without insomnia.

Main Methods:

• A cohort of 133 healthy college students (65 with insomnia, 68 without) were recruited.
• Participants underwent structured clinical interviews, psychiatric evaluations, physical examinations, and drug testing to rule out confounds.
• Influenza serum antibody levels (hemagglutination inhibition - HI) were measured before and four weeks after vaccination.

Main Results:

• Both groups showed increased antibody levels post-vaccination, indicating a general immune response.
• The insomnia group exhibited significantly lower overall HI antibody levels compared to the no-insomnia group.
• Exploratory analyses revealed significant interactions between Pittsburgh Sleep Quality Index (PSQI) scores and time, and insomnia status and time, on antibody levels.

Conclusions:

• Insomnia may be an independent risk factor for diminished immunity to the influenza virus.
• Lower antibody levels in the insomnia group suggest a potential impairment in immune response to vaccination.
• Further research is warranted to elucidate the mechanisms linking insomnia to altered immune function and vaccine response.